Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erman Guler"'
Autor:
Jonathan I Silverberg, Sonja Ständer, Jacob P Thyssen, Brian S Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G Bushmakin, Joseph C Cappelleri, Erman Guler, Justine Alderfer, Melissa Watkins, Gary Chan, Daniela E Myers
Publikováno v:
British Journal of Dermatology. 188
Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with itch, eczematous lesions and impaired quality of life (QoL). Although the frequency of skin pain in AD is often underestimated, it is associated with a substantial health b
Autor:
Jonathan I Silverberg, Eric L Simpson, Jacob P Thyssen, Andrew E Pink, Stephan Weidinger, Gary Chan, Irina Lazariciu, Claire Clibborn, Erman Guler
Publikováno v:
British Journal of Dermatology. 188
Abrocitinib, an oral, once-daily Janus kinase 1-selective inhibitor, had a superior efficacy vs. dupilumab in head-to-head randomized trials in moderate-to-severe atopic dermatitis (AD). Data on patients who switched from dupilumab to abrocitinib hav
Autor:
Jonathan I Silverberg, Sonja Ständer, Jacob P Thyssen, Brian S Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G Bushmakin, Joseph C Cappelleri, Erman Guler, Justine Alderfer, Melisa Watkins, Gary Chan, Daniela E Myers
Publikováno v:
British Journal of Dermatology. 188
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by intense itch, skin pain and impaired quality of life. Skin pain is a common and bothersome symptom of AD and increases in prevalence and intensity with worsening disease
Autor:
Jonathan I. Silverberg, Jacob P. Thyssen, Irina Lazariciu, Daniela E. Myers, Erman Güler, Raj Chovatiya
Publikováno v:
Skin Health and Disease, Vol 4, Iss 4, Pp n/a-n/a (2024)
Abstract Background Patients with atopic dermatitis (AD) exhibit heterogeneous clinical phenotypes, reflecting different combinations of itch and lesional severity. AD with severe itch but clear‐moderate lesions, also known as itch‐dominant AD, i
Externí odkaz:
https://doaj.org/article/f4788d16b96e41ab89d07dc665badc57
Autor:
Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, Melissa Watkins
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 9, Pp 1893-1907 (2023)
Abstract Abrocitinib is a Janus kinase (JAK) 1-selective inhibitor approved for the treatment of moderate-to-severe atopic dermatitis (AD). Although specific dose recommendations for abrocitinib vary across regional product labels, abrocitinib 100 mg
Externí odkaz:
https://doaj.org/article/910ab250dacb46cba12498d99a103afa
Publikováno v:
Materials & Design, Vol 196, Iss , Pp 109098- (2020)
Data-driven models are rising as an auspicious method for the geometrical design of materials and structural systems. Nevertheless, existing data-driven models customarily address the optimization of structural designs rather than metamaterial design
Externí odkaz:
https://doaj.org/article/dc6d7cda7db148f298f45a39bd8da6d5
Autor:
Erman Guleryuz, Sinisa Dj. Mesarovic
Publikováno v:
Crystals, Vol 6, Iss 7, p 77 (2016)
We investigate the mechanisms of incipient plasticity at low angle twist and asymmetric tilt boundaries in fcc metals. To observe plasticity of grain boundaries independently of the bulk plasticity, we simulate nanoindentation of bicrystals. On the l
Externí odkaz:
https://doaj.org/article/f5f84f72931141f6918f4c061c336bf8